Menu Expand
Mosby's 2016 Nursing Drug Reference - E-Book

Mosby's 2016 Nursing Drug Reference - E-Book

Linda Skidmore-Roth

(2015)

Additional Information

Book Details

Abstract

Choose the drug handbook trusted for nearly 30 years! The newest edition of a series that has been trusted by nurses for nearly 30 years, Mosby’s 2016 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled — including 20 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, highlighting of common and life-threatening side effects, and Safety Alert icons for situations requiring special attention. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides.

  • More than 5,000 generic and trade-name drugs are profiled, covering almost every drug you will administer in practice or in clinicals.
  • Comprehensive drug monographs include generic names, Rx or OTC availability, pronunciations, U.S. and Canadian trade names, functional and chemical classification, controlled-substance schedule, do-not-confuse drugs, action, uses, unlabeled uses, dosages and routes, available forms, side effects, contraindications, precautions, pharmacokinetics, interactions (including drug/herb, drug/food and drug lab test), nursing considerations, and treatment of overdose. 
  • Black Box Warnings provide alerts to dangerous or life-threatening adverse reactions. 
  • Common and life-threatening side effects are organized by body system, showing signs to watch for during assessments.
  • Safety Alert icon highlights the most critical interactions and side effects.
  • A companion website includes updates with recently approved drugs, a full-color pill atlas, drug dosage calculators, herbal products, Canadian drug information, patient teaching guidelines, and more.
  • Coverage of IV drug administration highlights dosage and IV administration instructions, including safety considerations and Y-site, syringe, and additive compatibilities.
  • Complete pharmacokinetic information includes the mechanism and absorption of the drug as well as its action, duration, and excretion.
  • Nursing Process steps are used as the framework for organizing all nursing care information.
  • Full-color design highlights important information, and an alphabetical organization by generic name provides quick and easy access.
  • Flexible, water-resistant cover provides durability in the clinical setting.
  • 20 NEW monographs provide up-to-date content on newly released drugs.

Table of Contents

Section Title Page Action Price
Front cover Cover
Inside Front Cover ES
Evolve ES
Antitoxins and antivenins ES
Abbreviations ES
Front matter i
Mosby’s NURSING DRUG REFERENCE 2016 29th Edition i
Copyright Page ii
Consultants iii
Preface iv
New Features iv
New Facts iv
Organization iv
Individual Drug Monographs iv
Appendixes v
Table of contents vii
Drug categories e1
α-ADRENERGIC BLOCKERS e1
ANESTHETICS—GENERAL/LOCAL e1
ANTACIDS e2
ANTI-ALZHEIMER AGENTS e3
ANTIANGINALS e4
ANTIANXIETY AGENTS e5
ANTIASTHMATICS e6
ANTICHOLINERGICS e8
ANTICOAGULANTS e9
ANTICONVULSANTS e10
ANTIDEPRESSANTS e11
ANTIDIABETICS e12
ANTIDIARRHEALS e13
ANTIDYSRHYTHMICS e14
ANTIEMETICS e15
ANTIFUNGALS (SYSTEMIC) e16
ANTIHISTAMINES e17
ANTIHYPERTENSIVES e18
ANTIINFECTIVES e20
ANTILIPIDEMICS e21
ANTINEOPLASTICS e22
ANTIPARKINSON AGENTS e24
ANTIPLATELETS e25
ANTIPSYCHOTICS e26
ANTIPYRETICS e27
ANTIRETROVIRALS e28
ANTITUBERCULARS e29
ANTITUSSIVES/EXPECTORANTS e30
ANTIVIRALS e31
β-ADRENERGIC BLOCKERS e32
BONE RESORPTION INHIBITORS e33
CALCIUM CHANNEL BLOCKERS e34
CARDIAC GLYCOSIDES e35
CHOLINERGICS e36
CHOLINERGIC BLOCKERS e36
CORTICOSTEROIDS e37
DIURETICS e39
HISTAMINE H₂ ANTAGONISTS e40
IMMUNOSUPPRESSANTS e41
LAXATIVES e42
NEUROMUSCULAR BLOCKING AGENTS e43
NONSTEROIDAL ANTIINFLAMMATORIES e44
OPIOID ANALGESICS e45
SALICYLATES e46
SEDATIVES/HYPNOTICS e47
SKELETAL MUSCLE RELAXANTS e48
THROMBOLYTICS e49
THYROID HORMONES e50
VASODILATORS e51
VITAMINS e52
A e53
A 1
B e54
B 119
C e55
C 176
CALCIUM SALTS 181
CEPHALOSPORINS—1ST GENERATION 213
CEPHALOSPORINS—2ND GENERATION 216
CEPHALOSPORINS—3RD/4TH GENERATION 181
CONTRACEPTIVES, HORMONAL 288
Monophasic, Oral 288
D e57
D 309
E e58
E 410
F e59
F 482
G e60
G 545
H e61
H 573
I e62
I 598
INSULINS 629
Rapid Acting 629
insulin glulisine (Rx) 629
insulin aspart (Rx) 629
insulin lispro (Rx) 629
Short Acting 629
insulin, regular (OTC) 629
insulin, regular concentrated (Rx) 629
Intermediate Acting 629
insulin, isophane suspension (NPH) (OTC) 629
Long Acting 629
insulin detemir (Rx) 629
insulin glargine (Rx) 629
Mixtures 629
insulin, isophane suspension and regular insulin (Rx) 629
isophane insulin suspension (NPH) and insulin mixtures (Rx) 630
insulin lispro mixture (Rx) 630
insulin aspart mixture (Rx) 630
K e63
K 655
L e64
L 662
M e65
M 721
N e66
N 810
O e67
O 855
P e68
P 887
PENICILLINS 913
Q e69
Q 981
R e70
R 988
S e71
S 1042
T e72
T 1087
U e73
U 1182
V e74
V 1183
W e75
W 1219
Z e76
Z 1221
Appendix A e77
Appendix A Selected new drugs 1236
Appendix B e78
Appendix B Ophthalmic, otic, nasal, and topical products 1256
OPHTHALMIC PRODUCTS 1256
ANESTHETICS 1256
lidocaine (Rx) 1256
proparacaine (Rx) 1256
tetracaine (Rx) 1256
ANTIHISTAMINES 1256
alcaftadine (Rx) 1256
emedastine (Rx) 1256
olopatadine (Rx) 1256
ANTIINFECTIVES 1256
azithromycin (Rx) 1256
besifloxacin (Rx) 1256
ganciclovir (Rx) 1256
levofloxacin (Rx) 1256
natamycin (Rx) 1256
ofloxacin (Rx) 1256
silver nitrate 1% (Rx) 1256
silver nitrate 1256
sulfacetamide sodium (Rx) 1256
tobramycin (Rx) 1256
trifluridine (Rx) 1256
β-ADRENERGIC BLOCKERS 1256
betaxolol (Rx) 1256
levobunolol (Rx) 1256
metipranolol (Rx) 1256
CARBONIC ANHYDRASE INHIBITORS 1256
brinzolamide (Rx) 1256
CHOLINERGICS (Direct-acting) 1257
acetylcholine Rx) 1257
carbachol (Rx) 1257
pilocarpine (Rx) 1257
CHOLINESTERASE INHIBITORS 1257
echothiophate (Rx) 1257
CORTICOSTEROIDS 1257
fluocinolone (Rx) 1257
fluorometholone (Rx) 1257
loteprednol (Rx) 1257
prednisoLONE (Rx) 1257
rimexolone (Rx) 1257
MYDRIATICS 1257
atropine (Rx) 1257
cyclopentolate (Rx) 1257
homatropine (Rx) 1257
phenylephrine (OTC) 1257
scopolamine (Rx) 1257
tropicamide (Rx) 1257
NONSTEROIDAL ANTIINFLAMMATORIES 1257
diclofenac (Rx) 1257
flurbiprofen (Rx) 1257
nepafenac (Rx) 1257
SYMPATHOMIMETICS 1257
apraclonidine (Rx) 1257
OPHTHALMIC DECONGESTANTS/ VASOCONSTRICTORS 1257
lodoxamide 1257
oxymetazoline (Rx) 1257
tetrahydrozoline (OTC) 1257
MISCELLANEOUS OPHTHALMICS 1258
travoprost (Rx) 1258
unoprostone (Rx) 1258
β-Adrenergic blockers 1258
Anesthetics 1258
Antiinfectives 1258
Antiinflammatories 1258
Carbonic anhydrase inhibitor 1258
Direct-acting miotic 1258
NASAL AGENTS 1259
NASAL ANTIHISTAMINES 1259
NASAL DECONGESTANTS 1259
azelastine (Rx) 1259
desoxyephedrine (OTC) 1259
EPINEPHrine (OTC) 1259
oxymetazoline (OTC) 1259
phenylephrine (OTC) 1259
tetrahydrozoline (OTC) 1259
NASAL CORTICOSTEROIDS 1259
budesonide (Rx) 1259
fluticasone (Rx) 1259
triamcinolone (Rx) 1259
NONSTEROIDAL ANTIINFLAMMATORY 1259
ketorolac (Rx) 1259
TOPICAL GLUCOCORTICOIDS 1260
TOPICAL ANTIFUNGALS 1261
TOPICAL ANTIINFECTIVES 1262
TOPICAL ANTIVIRALS 1263
TOPICAL ANESTHETICS 1263
TOPICAL MISCELLANEOUS 1264
VAGINAL ANTIFUNGALS 1265
OTIC ANTIINFECTIVES 1265
Appendix C Vaccines and toxoids 1267
Appendix D Recent FDA drug approvals 1273
Index 1274
A 1274
B 1280
C 1283
D 1289
E 1292
F 1295
G 1296
H 1298
I 1302
J 1304
K 1304
L 1305
M 1307
N 1311
O 1313
P 1316
Q 1321
R 1322
S 1324
T 1328
U 1331
V 1332
W 1333
X 1334
Y 1334
Z 1334
End sheets ES
Formulas ES
Surface area rule: ES
Calculating strength of a solution: ES
Calculating flow rate for IV: ES
Calculation of medication dosages: ES
Formula method: ES
Ratio–proportion method: ES
Dimensional analysis method: ES
Temperature conversion: ES
Nomogram for calculation of body surface area ES